Sinoway Industrial Co., Ltd.

Sofosbuvir 1190307-88-0 Sofosbuvir 1190307-88-0

Sofosbuvir 1190307-88-0
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Sofosbuvir 1190307-88-0

  • Other name: GS-7977;N-[[P(S),2'R]-2'-Deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-L-alanine 1-methylethyl ester;PSI 7977;sofosbuvir;GS-7977/sofosbuvir;sofosbuvir, PSI7977;(S)-isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-Methyltetrahydrofuran-2-yl)Methoxy)(phenoxy)phosphoryl)aMino)propanoate;PSI-7977 Discontinued
  • Molecular Formula: C22H29FN3O9P
  • Molecular Weight: 529.4525242
  • CAS No.: 1190307-88-0
  • Appearance: white crystalline powder
  • Puity: 99.0% up by HPLC

Usage of Sofosbuvir 1190307-88-0

  • Sofosbuvir is a drug used for hepatitis C virus (HCV) infection, with a high cure rate. It inhibits the RNA polymerase that the hepatitis C virus uses to replicate its RNA. It was discovered at  Pharmasset and developed by Gilead Sciences. Sofosbuvir is a component of the first all-oral, interferon-free regimen approved for treating chronic hepatitis C.

COA of Sofosbuvir 1190307-88-0

Items

Specifications

Appearance

White Crystalline powder

Identification

HPLC RT

Loss on drying

≤1.0%

Residue on ignition

≤1.0%

Total impurity

≤1.0%

Purity(HPLC)

≥99.0%

EE

99%

Conclusion

Comply with the standard.


MORE_DETAIL Sofosbuvir 1190307-88-0

Basic information of Sofosbuvir 1190307-88-0

  • Other name: GS-7977;N-[[P(S),2'R]-2'-Deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-L-alanine 1-methylethyl ester;PSI 7977;sofosbuvir;GS-7977/sofosbuvir;sofosbuvir, PSI7977;(S)-isopropyl 2-(((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-Methyltetrahydrofuran-2-yl)Methoxy)(phenoxy)phosphoryl)aMino)propanoate;PSI-7977 Discontinued
  • Molecular Formula: C22H29FN3O9P
  • Molecular Weight: 529.4525242
  • CAS No.: 1190307-88-0
  • Appearance: white crystalline powder
  • Puity: 99.0% up by HPLC

Usage of Sofosbuvir 1190307-88-0

  • Sofosbuvir is a drug used for hepatitis C virus (HCV) infection, with a high cure rate. It inhibits the RNA polymerase that the hepatitis C virus uses to replicate its RNA. It was discovered at  Pharmasset and developed by Gilead Sciences. Sofosbuvir is a component of the first all-oral, interferon-free regimen approved for treating chronic hepatitis C.

COA of Sofosbuvir 1190307-88-0

Items

Specifications

Appearance

White Crystalline powder

Identification

HPLC RT

Loss on drying

≤1.0%

Residue on ignition

≤1.0%

Total impurity

≤1.0%

Purity(HPLC)

≥99.0%

EE

99%

Conclusion

Comply with the standard.

Related Articles
Leave a Message Email Us

we will contact you within 24 hours.

  • TEL:+86-0592-5854962
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//